Optimizing therapy of seizures in adult patients with psychiatric comorbidity

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Brodtkorb, Eylert ^a,b   Mula, Marco ^c,d  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; LAMOTRIGINE; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PSYCHOTROPIC AGENT; REBOXETINE; SERTRALINE; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VIGABATRIN; ZONISAMIDE;

AGGRESSION; AGITATION; ANTICONVULSANT THERAPY; ANXIETY; BEHAVIOR DISORDER; BIPOLAR DISORDER; BONE MARROW DISEASE; BRAIN DISEASE; COMORBIDITY; DEPRESSION; DRUG METABOLISM; DRUG POTENTIATION; EPILEPSY; HUMAN; HYPERACTIVITY; INSOMNIA; IRRITABILITY; MENTAL DISEASE; MENTAL INSTABILITY; MENTAL PATIENT; NERVE STIMULATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL PHOBIA; SOCIAL PSYCHOLOGY; TREMOR; VAGUS NERVE; WEIGHT GAIN;

EID: 33845693026     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s39     Document Type: Review

References (40)

1. Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004;110:207-220.
2. Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53(suppl 2):53-67.
3. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saft 2002;25:91-110.
4. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(suppl 5):9-20.
5. Helde G, Bovim G, Brathen G, Brodtkorb E. A structured nurse-led intervention program improves quality of life in patients with epilepsy: a randomised controlled trial. Epilepsy Behav 2005;7:451-457.
6. Schachter SC. Improving quality of life beyond seizure control. Epileptic Disord 2005;7(suppl 1):34-38.
7. Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA. Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav 2004;6:85-89.
8. Ramaratnam S, Baker GA, Goldstein L. Psychological treatments for epilepsy. Cochrane Database Syst Rev 2003;4:CD002029.
9. Helde G, Brodtkorb E, Brathen G, Bovim G. An easily performed group education programme for patients with uncontrolled epilepsy - a pilot study. Seizure 2003;12:497-501.
10. Boylan LS, Devinsky O, Barry JJ, Ketter TA. Psychiatric uses of antiepileptic treatments. Epilepsy Behav 2002;3(suppl):54-59.
11. Mula M, Trimble MR, Sander JW. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 2003;44:1573-1577.
12. Krishnamoorthy ES, Trimble MR. Forced normalization: clinical and therapeutic relevance. Epilepsia 1999;40(suppl 10):57-64.
13. Brodtkorb E. Management of epilepsy in people with learning disability. In: Shorvon SD, Perucca E, Fish DR, Dodson WE, eds. The treatment of epilepsy. 2nd edition. Malden, MA: Blackwell Science, 2004
14. Ovsiew F. Antiepileptic drugs in psychiatry. J Neurol Neurosurg Psychiatry 2004;75:1655-1658.
15. Hirsch E, Schmitz B, Carreno M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand 2003;180(suppl):23-32.
16. Schmitz B. Psychiatric syndromes related to antiepileptic drugs. Epilepsia 1999;40(suppl 10):65-70.
17. Besag FM. Behavioral effects of the newer antiepileptic drugs: an update. Expert Opin Drug Saft 2004;3:1-8.
18. Nadkarni S, Devinsky O. Psychotropic effects of antiepileptic drugs. Epilepsy Currents 2005;5:176-181.
19. Mula M, Monaco F, Trimble MR. Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk. Expert Rev Neurotherapeutics 2004;4:953-964.
20. Cramer JA, Hammer AE, Kustra RP. Improved mood states with lamotrigine in patients with epilepsy. Epilepsy Behav 2004;5:702-707.
21. Pande AC, Feltner DE, Jefferson JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol 2004;24:141-149.
22. Spina E, Perucca E. Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. Epilepsia 2002;43(suppl 2):37-44.
23. Mula M, Monaco F. Antiepileptic-antipsychotic drug interactions. A critical review of the evidence. Clin Neuropharmacol 2002;25:280-289.
24. Mula M, Trimble MR. Pharmacokinetic interactions between antiepileptic and antidepressant drugs. World J Biol Psychiatry 2003;4:21-24.
25. Reimers A, Skogvoll E, Sund JK, Spigset OJ. Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. Clin Psychopharmacol 2005;25:342-348.
26. Kaufman KR, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure 1998;7:163-165.
27. Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia 2002;43(suppl 2):19-24.
28. Ojemann LM, Baugh-Bookman C, Dudley DL. Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology 1987;37:1525-1527.
29. Jobe PC, Dailey JW, Wernicke JF. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 1999;13:317-356.
30. Schmitz B. Antidepressant drugs: indications and guidelines for use in epilepsy. Epilepsia 2002;43(suppl 2):13-18.
31. Beyenburg S, Mitchell AJ, Schmidt D, Elger CE, Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav 2005;7:161-171.
32. Reutens DC, Savard G, Andermann F, Dubeau F, Olivier A. Results of surgical treatment in temporal lobe epilepsy with chronic psychosis. Brain 1997;120:1929-1936.
33. Marchetti RL, Fiore LA, Valente KD, Gronich G, Nogueira AB, Tzu WH. Surgical treatment of temporal lobe epilepsy with interictal psychosis: results of six cases. Epilepsy Behav 2003;4:146-152.
34. Shaw P, Mellers J, Henderson M, Polkey C, David AS, Toone BK. Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. J Neurol Neurosurg Psychiatry 2004;75:1003-1008.
35. Reuber M, Andersen B, Elger CE, Helmstaedter C. Depression and anxiety before and after temporal lobe epilepsy surgery. Seizure 2004;13:29-35.
36. Wilson SJ, Bladin PF, Saling MM. Paradoxical results in the cure of chronic illness: the "burden of normality" as exemplified following seizure surgery. Epilepsy Behav 2004;5:13-21.
37. Naga AA, Devinsky O, Barr WB. Somatoform disorders after temporal lobectomy. Cogn Behav Neurol 2004;17:57-61.
38. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 2005;29:493-500.
39. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005;58:355-363.
40. Schachter S. Vagus nerve stimulation: mood and cognitive effects. Epilepsy Behav 2004;6(suppl 1):6-9.